Coursework type: ESSAY for pharmacology module word limit:1000 (strict limit excluding references, tables, legends, graphs, annotations etc.) Essay title: A startup company has discovered a compound that blocks D2 dopamine receptors with an unprecedented selectivity and acts as a partial agonist of beta1 adrenergic receptors. The pIC50 of its action on D2 is 9.3 and its EC50 at beta1 receptors is 10-4.3 M. What conditions might this compound potentially be useful for? What possible limitations might arise when using the lead compound for those conditions you have suggested?
- Use the internet to investigate Russian and American cooperative involvement with the International Space Station. What have both countries contr
- Name and describe at least two non-traditional healing systems Discuss the interface between religion and mental health Religion, Healing and
- Watch and annotate the videos of one peer as assigned by your instructor on InTASC Standards 1, 2, and 3 of the Clinical Practice Rubric. * Use t
- Discuss some of the elements in women?s approach to power, negotiation, and risk-taking that may lead to them earning less than men in similar jo
- Explain how your organizational design and culture could be implemented at your workplace or organization. Explain how your design will improve
- You need to develop a specific activity that is for the vignette that you chose. You also have to list all the rules, all the consequences, and all the materia
- The student will provide a description of the administration, logistics, and planning for a sport ministry project of the student?s choice. The portfolio must
- For this assignment, you have just been hired as the new Head Coach (of your particular sport) at Amos University! First…Your Bad News You have inherited a t
- The CEO of your organization wants to improve employee morale. Recently, she went to a conference at which she heard people talking about ?open-book management
- Maya has just been hired as the chief executive officer (CEO) to turn around Phoenix Solutions, a once-thriving tech company now struggling with declining reve